US Stock Market Move | Weight loss drug concept stocks are strong, with Suodi Biotech (GPCR.US) rising more than 5%.

On Wednesday, the concept stocks of weight loss drugs in the US stock market performed well. As of the deadline, Shodex Biotechnology (GPCR.US) rose by over 5%, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rose by over 3.5%, Roche (RHHBY.US) rose by over 3%, and Eli Lilly (LLY.US) rose slightly. In terms of news, Shodex Biotechnology previously announced positive top-line results for its once-daily, orally administered small molecule GLP-1 receptor agonist aleniglipron in the ACCESS clinical trial.